Role of the glucosamine pathway in fat-induced insulin resistance

Meredith A. Hawkins, Nir Barzilai, Rong Liu, Meizhu Hu, Wei Chen, Luciano Rossetti

Research output: Contribution to journalArticle

246 Citations (Scopus)

Abstract

To examine whether the hexosamine biosynthetic pathway might play a role in fat-induced insulin resistance, we monitored the effects of prolonged elevations in FFA availability both on skeletal muscle levels of UDP-N- acetyl-hexosamines and on peripheral glucose disposal during 7-h euglycemic- hyperinsulinemic (~500 μU/ml) clamp studies. When the insulin-induced decrease in the plasma FFA levels (to ~ 0.3 mM) was prevented by infusion of a lipid emulsion in 15 conscious rats (plasma FFA ~ 1.4 mM), glucose uptake (5-7 h = 32.5 ± 1.7 vs 0-2 h = 45.2±2.8 mg/kg per min; P < 0.01) and glycogen synthesis (P < 0.01) were markedly decreased. During lipid infusion, muscle UDP-N-acetyl-glucosamine (UDP-GlcNAc) increased by twofold (to 53.4±1.1 at 3 h and to 55.5±1.1 nmol/gram at 7 h vs 20.4±1.7 at 0 h, P < 0.01) while glucose-6-phosphate (Glc-6-P) levels were increased at 3 h (475±49 nmol/gram) and decreased at 7 h (133±7 vs 337±28 nmol/gram at 0 h, P < 0.01). To discern whether such an increase in the skeletal muscle UDP- GlcNAc concentration could account for the development of insulin resistance, we generated similar increases in muscle UDP-GlcNAc using three alternate experimental approaches. Euglycemic clamps were performed after prolonged hyperglycemia (18 mM, n = 10), or increased availability of either glucosamine (3 μmol/kg per min; n = 10) or uridine (30 μmol/kg per min; n = 4). These conditions all resulted in very similar increases in the skeletal muscle UDP-GlcNAc (to ~ 55 nmol/gram)and markedly impaired glucose uptake and glycogen synthesis. Thus, fat-induced insulin resistance is associated with: (a) decreased skeletal muscle Glc-6-P levels indicating defective transport/phosphorylation of glucose; (b) marked accumulation of the endproducts of the hexosamine biosynthetic pathway preceding the onset of insulin resistance. Most important, the same degree of insulin resistance can be reproduced in the absence of increased FFA availability by a similar increase in skeletal muscle UDP-N-acetyl-hexosamines. In conclusion, our results support the hypothesis that increased FFA availability induces skeletal muscle insulin resistance by increasing the flux of fructose-6- phosphate into the hexosamine pathway.

Original languageEnglish (US)
Pages (from-to)2173-2182
Number of pages10
JournalJournal of Clinical Investigation
Volume99
Issue number9
StatePublished - May 1 1997

Fingerprint

Uridine Diphosphate
Glucosamine
Hexosamines
Insulin Resistance
Skeletal Muscle
Fats
Glucose
Glucose-6-Phosphate
Biosynthetic Pathways
Glycogen
Lipids
Muscles
Glucose Clamp Technique
Uridine
Emulsions
Hyperglycemia
Phosphorylation
Insulin

Keywords

  • free fatty acids
  • glucosamine
  • glucose uptake
  • insulin resistance
  • UDP-N-acetyl- glucosamine

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Role of the glucosamine pathway in fat-induced insulin resistance. / Hawkins, Meredith A.; Barzilai, Nir; Liu, Rong; Hu, Meizhu; Chen, Wei; Rossetti, Luciano.

In: Journal of Clinical Investigation, Vol. 99, No. 9, 01.05.1997, p. 2173-2182.

Research output: Contribution to journalArticle

Hawkins, Meredith A. ; Barzilai, Nir ; Liu, Rong ; Hu, Meizhu ; Chen, Wei ; Rossetti, Luciano. / Role of the glucosamine pathway in fat-induced insulin resistance. In: Journal of Clinical Investigation. 1997 ; Vol. 99, No. 9. pp. 2173-2182.
@article{383a679f2e504c10a28b3fb13c89f0cf,
title = "Role of the glucosamine pathway in fat-induced insulin resistance",
abstract = "To examine whether the hexosamine biosynthetic pathway might play a role in fat-induced insulin resistance, we monitored the effects of prolonged elevations in FFA availability both on skeletal muscle levels of UDP-N- acetyl-hexosamines and on peripheral glucose disposal during 7-h euglycemic- hyperinsulinemic (~500 μU/ml) clamp studies. When the insulin-induced decrease in the plasma FFA levels (to ~ 0.3 mM) was prevented by infusion of a lipid emulsion in 15 conscious rats (plasma FFA ~ 1.4 mM), glucose uptake (5-7 h = 32.5 ± 1.7 vs 0-2 h = 45.2±2.8 mg/kg per min; P < 0.01) and glycogen synthesis (P < 0.01) were markedly decreased. During lipid infusion, muscle UDP-N-acetyl-glucosamine (UDP-GlcNAc) increased by twofold (to 53.4±1.1 at 3 h and to 55.5±1.1 nmol/gram at 7 h vs 20.4±1.7 at 0 h, P < 0.01) while glucose-6-phosphate (Glc-6-P) levels were increased at 3 h (475±49 nmol/gram) and decreased at 7 h (133±7 vs 337±28 nmol/gram at 0 h, P < 0.01). To discern whether such an increase in the skeletal muscle UDP- GlcNAc concentration could account for the development of insulin resistance, we generated similar increases in muscle UDP-GlcNAc using three alternate experimental approaches. Euglycemic clamps were performed after prolonged hyperglycemia (18 mM, n = 10), or increased availability of either glucosamine (3 μmol/kg per min; n = 10) or uridine (30 μmol/kg per min; n = 4). These conditions all resulted in very similar increases in the skeletal muscle UDP-GlcNAc (to ~ 55 nmol/gram)and markedly impaired glucose uptake and glycogen synthesis. Thus, fat-induced insulin resistance is associated with: (a) decreased skeletal muscle Glc-6-P levels indicating defective transport/phosphorylation of glucose; (b) marked accumulation of the endproducts of the hexosamine biosynthetic pathway preceding the onset of insulin resistance. Most important, the same degree of insulin resistance can be reproduced in the absence of increased FFA availability by a similar increase in skeletal muscle UDP-N-acetyl-hexosamines. In conclusion, our results support the hypothesis that increased FFA availability induces skeletal muscle insulin resistance by increasing the flux of fructose-6- phosphate into the hexosamine pathway.",
keywords = "free fatty acids, glucosamine, glucose uptake, insulin resistance, UDP-N-acetyl- glucosamine",
author = "Hawkins, {Meredith A.} and Nir Barzilai and Rong Liu and Meizhu Hu and Wei Chen and Luciano Rossetti",
year = "1997",
month = "5",
day = "1",
language = "English (US)",
volume = "99",
pages = "2173--2182",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "9",

}

TY - JOUR

T1 - Role of the glucosamine pathway in fat-induced insulin resistance

AU - Hawkins, Meredith A.

AU - Barzilai, Nir

AU - Liu, Rong

AU - Hu, Meizhu

AU - Chen, Wei

AU - Rossetti, Luciano

PY - 1997/5/1

Y1 - 1997/5/1

N2 - To examine whether the hexosamine biosynthetic pathway might play a role in fat-induced insulin resistance, we monitored the effects of prolonged elevations in FFA availability both on skeletal muscle levels of UDP-N- acetyl-hexosamines and on peripheral glucose disposal during 7-h euglycemic- hyperinsulinemic (~500 μU/ml) clamp studies. When the insulin-induced decrease in the plasma FFA levels (to ~ 0.3 mM) was prevented by infusion of a lipid emulsion in 15 conscious rats (plasma FFA ~ 1.4 mM), glucose uptake (5-7 h = 32.5 ± 1.7 vs 0-2 h = 45.2±2.8 mg/kg per min; P < 0.01) and glycogen synthesis (P < 0.01) were markedly decreased. During lipid infusion, muscle UDP-N-acetyl-glucosamine (UDP-GlcNAc) increased by twofold (to 53.4±1.1 at 3 h and to 55.5±1.1 nmol/gram at 7 h vs 20.4±1.7 at 0 h, P < 0.01) while glucose-6-phosphate (Glc-6-P) levels were increased at 3 h (475±49 nmol/gram) and decreased at 7 h (133±7 vs 337±28 nmol/gram at 0 h, P < 0.01). To discern whether such an increase in the skeletal muscle UDP- GlcNAc concentration could account for the development of insulin resistance, we generated similar increases in muscle UDP-GlcNAc using three alternate experimental approaches. Euglycemic clamps were performed after prolonged hyperglycemia (18 mM, n = 10), or increased availability of either glucosamine (3 μmol/kg per min; n = 10) or uridine (30 μmol/kg per min; n = 4). These conditions all resulted in very similar increases in the skeletal muscle UDP-GlcNAc (to ~ 55 nmol/gram)and markedly impaired glucose uptake and glycogen synthesis. Thus, fat-induced insulin resistance is associated with: (a) decreased skeletal muscle Glc-6-P levels indicating defective transport/phosphorylation of glucose; (b) marked accumulation of the endproducts of the hexosamine biosynthetic pathway preceding the onset of insulin resistance. Most important, the same degree of insulin resistance can be reproduced in the absence of increased FFA availability by a similar increase in skeletal muscle UDP-N-acetyl-hexosamines. In conclusion, our results support the hypothesis that increased FFA availability induces skeletal muscle insulin resistance by increasing the flux of fructose-6- phosphate into the hexosamine pathway.

AB - To examine whether the hexosamine biosynthetic pathway might play a role in fat-induced insulin resistance, we monitored the effects of prolonged elevations in FFA availability both on skeletal muscle levels of UDP-N- acetyl-hexosamines and on peripheral glucose disposal during 7-h euglycemic- hyperinsulinemic (~500 μU/ml) clamp studies. When the insulin-induced decrease in the plasma FFA levels (to ~ 0.3 mM) was prevented by infusion of a lipid emulsion in 15 conscious rats (plasma FFA ~ 1.4 mM), glucose uptake (5-7 h = 32.5 ± 1.7 vs 0-2 h = 45.2±2.8 mg/kg per min; P < 0.01) and glycogen synthesis (P < 0.01) were markedly decreased. During lipid infusion, muscle UDP-N-acetyl-glucosamine (UDP-GlcNAc) increased by twofold (to 53.4±1.1 at 3 h and to 55.5±1.1 nmol/gram at 7 h vs 20.4±1.7 at 0 h, P < 0.01) while glucose-6-phosphate (Glc-6-P) levels were increased at 3 h (475±49 nmol/gram) and decreased at 7 h (133±7 vs 337±28 nmol/gram at 0 h, P < 0.01). To discern whether such an increase in the skeletal muscle UDP- GlcNAc concentration could account for the development of insulin resistance, we generated similar increases in muscle UDP-GlcNAc using three alternate experimental approaches. Euglycemic clamps were performed after prolonged hyperglycemia (18 mM, n = 10), or increased availability of either glucosamine (3 μmol/kg per min; n = 10) or uridine (30 μmol/kg per min; n = 4). These conditions all resulted in very similar increases in the skeletal muscle UDP-GlcNAc (to ~ 55 nmol/gram)and markedly impaired glucose uptake and glycogen synthesis. Thus, fat-induced insulin resistance is associated with: (a) decreased skeletal muscle Glc-6-P levels indicating defective transport/phosphorylation of glucose; (b) marked accumulation of the endproducts of the hexosamine biosynthetic pathway preceding the onset of insulin resistance. Most important, the same degree of insulin resistance can be reproduced in the absence of increased FFA availability by a similar increase in skeletal muscle UDP-N-acetyl-hexosamines. In conclusion, our results support the hypothesis that increased FFA availability induces skeletal muscle insulin resistance by increasing the flux of fructose-6- phosphate into the hexosamine pathway.

KW - free fatty acids

KW - glucosamine

KW - glucose uptake

KW - insulin resistance

KW - UDP-N-acetyl- glucosamine

UR - http://www.scopus.com/inward/record.url?scp=0030926433&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030926433&partnerID=8YFLogxK

M3 - Article

VL - 99

SP - 2173

EP - 2182

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 9

ER -